Literature DB >> 12628729

Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve.

Eduardo Balcells1, Eric R Powers, Wolfgang Lepper, Todd Belcik, Kevin Wei, Michael Ragosta, Habib Samady, Jonathan R Lindner.   

Abstract

OBJECTIVES: We sought to determine whether myocardial contrast echocardiography (MCE) performed before and early after primary coronary stenting (PCS) in patients with acute myocardial infarction (AMI) could predict recovery of resting left ventricular systolic function and contractile reserve.
BACKGROUND: Myocardial contrast echocardiography can be used to assess perfusion within the risk area before PCS and the extent of necrosis soon after PCS.
METHODS: In 30 patients with AMI, MCE and two-dimensional echocardiography were performed before PCS and 3 to 5 days and 4 weeks after PCS. Contractile reserve was assessed by dobutamine echocardiography at four weeks in patients with persistent severe wall-motion abnormalities.
RESULTS: Of segments without perfusion at 3 to 5 days, 95% had severe hypokinesis to akinesis at 4 weeks. Of segments with normal perfusion at 3 to 5 days, 90% had normal wall motion or mild hypokinesis at 4 weeks, whereas those with partial perfusion at 3 to 5 days were evenly divided between normal wall motion, hypokinesis, and akinesis. In segments with persistent severe wall-motion abnormalities at four weeks, contractile reserve was found in >80% of segments with perfusion, compared with only 10% of segments without detectable perfusion (p < 0.01). The presence of myocardial perfusion by MCE before PCS was associated with maintained or improved perfusion at 3 to 5 days and eventual recovery of resting wall motion.
CONCLUSIONS: Myocardial contrast echocardiography performed early after PCS provides information on the extent of infarction, and hence the likelihood for recovery of resting systolic function or contractile reserve. The presence of perfusion before PCS, from either collateral or antegrade flow, predicts the maintenance of perfusion and recovery of systolic function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628729     DOI: 10.1016/s0735-1097(02)02962-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Microvascular Impairment After Myocardial Infarction: It Is Not Just About Obstruction.

Authors:  Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2020-06-12       Impact factor: 7.792

2.  Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.

Authors:  Kambiz Kalantarinia; Mark D Okusa
Journal:  Drug Discov Today Dis Mech       Date:  2007

3.  Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound.

Authors:  Kambiz Kalantarinia; J Todd Belcik; James T Patrie; Kevin Wei
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-22

Review 4.  Myocardial perfusion imaging with contrast echocardiography.

Authors:  Chad L Carr; Jonathan R Lindner
Journal:  Curr Cardiol Rep       Date:  2008-05       Impact factor: 2.931

Review 5.  Myocardial contrast echocardiography after myocardial infarction.

Authors:  Hiroshi Ito
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 6.  Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: methodology and clinical applications.

Authors:  Abdou Elhendy; Thomas R Porter
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

7.  Contrast echocardiography accurately predicts myocardial perfusion before angiography during acute myocardial infarction.

Authors:  Gregory B Schnell; Albert J Kryski; Luana Mann; Todd J Anderson; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

8.  Evaluation of myocardial viability after myocardial infarction with intravenous real-time myocardial contrast echocardiography.

Authors:  Weihui Shentu; Youbin Deng; Runqing Huang; Peng Li; Xiang Wei; Haoyi Yang; Yun Zhang; Li Xiong; Fen Yu; Yuhan Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

Review 9.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

Review 10.  Novel imaging techniques in acute kidney injury.

Authors:  Kambiz Kalantarinia
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.